Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 22/11/2020
SIETES contiene 93161 citas

 
 
<< anterior 21 a 40 de 131 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Lenzer J, Brownlee S. Why the FDA can't protect the public. BMJ 2010;341:966-8. [Ref.ID 89619]
22.Tiene citas relacionadas Cita con resumen
Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 2010;376:1670-81. [Ref.ID 89326]
23.Tiene citas relacionadas
24.Tiene citas relacionadas Cita con resumen
Patorno E, Bohn RL, Wahl PM, Avorn J, Patrick AR, Liu J, Schneeweiss S. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA 2010;303:1401-9. [Ref.ID 88264]
25. Cita con resumen
Frank KM, Hogarth DK, Miller JL, Mandal S, Mease PJ, Samulski RJ, Weisgerber GA, Hart J. Investigation of the cause of death in a gene-therapy trial. N Engl J Med 2009;361:161-9. [Ref.ID 86169]
26.Tiene citas relacionadas
Hohnloser SH, van Eickels M, Connolly SJ. Dronedarone in atrial fibrillation. The authors reply. N Engl J Med 2009;360:2480-1. [Ref.ID 85990]
27.Tiene citas relacionadas
Floyd J. Dronedarone in atrial fibrillation. N Engl J Med 2009;360:2480. [Ref.ID 85989]
28.Tiene citas relacionadas
Horner SM. Dronedarone in atrial fibrillation. N Engl J Med 2009;360:2480. [Ref.ID 85988]
29.Tiene citas relacionadas
Pugliano M, Costantino G, Podda GM, for Gruppo di Autoformazione Metodologica. Dronedarone in atrial fibrillation. N Engl J Med 2009;360:2479-80. [Ref.ID 85987]
30.Tiene citas relacionadas
Tejani AM, Yih V. Dronedarone in atrial fibrillation. N Engl J Med 2009;360:2479. [Ref.ID 85986]
31. Cita con resumen
González Fernández C, González Castro A, López Sánchez M, Rodríguez Barregán JC. Intento autolítico por abuso de carbimida y alcohol con resultado fatal. Med Clin (Barc) 2009;132:683-4. [Ref.ID 85905]
32.Tiene citas relacionadas
Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R, for the HORIZONS-AMI Trial Investigators. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 2009;360:1946-59. [Ref.ID 85773]
33.Tiene citas relacionadas
James SK, Stenestrand U, Lindbäck J, Carlsson J, Scherstén F, Nilsson T, Wallentin L, Lagerqvist B, for the SCAAR Study Group. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 2009;360:1933-45. [Ref.ID 85772]
34. Cita con resumen
Sutter S. US FDA eases warnings for Roche's Rocephin. Scrip 2009;3442:13. [Ref.ID 85685]
35. Cita con resumen
Kuehn BM. Efforts aim to curb opioid deaths, injuries. JAMA 2009;301:1213-5. [Ref.ID 85511]
36.Enlace a cita original
Hall GC. Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf 2009;18:120-31. [Ref.ID 85254]
37. Cita con resumen
Hohnloser SH, Crijns HJGM, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ, for the ATEHNA Investigators. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-78. [Ref.ID 85242]
38.Enlace a cita original Cita con resumen
Kuehn BM. FDA Panel: ban 2 popular asthma drugs. JAMA 2009;301:365-6. [Ref.ID 85108]
39.Enlace a cita original
Anónimo. Ceftriaxone. Fatal reactions with calcium. Canada. WHO Pharmaceuticals Newsletter 2008;4:4. [Ref.ID 84846]
40. Cita con resumen
Anónimo. Enrichir sa panoplie thérapeutique. Bilan de l'année 2008. Rhumatologie. Prescrire 2009;29:53-4. [Ref.ID 84827]
Seleccionar todas
 
<< anterior 21 a 40 de 131 siguiente >>